An Follow-up Study of Occlusal Adjustment for Orofacial Pain
Launched by MEIQING WANG · Aug 2, 2016
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying orofacial pain, particularly a type called trigeminal neuralgia, to understand how the way teeth come together (occlusion) may relate to this pain. Researchers want to find out if adjusting how the teeth fit together can help relieve this kind of pain, which can be very uncomfortable and difficult to treat with regular medications or surgeries.
To participate in this study, you must be experiencing orofacial pain that has not improved with treatments like medication or dental procedures. You should meet certain criteria, such as having intense, brief, electric shock-like pain focused in your face or ongoing dull pain that lasts more than two hours each day for over three months. The study is open to both men and women aged 65 and older. If you join the study, you can expect to undergo evaluations related to your pain and possibly receive an occlusal adjustment to see if it helps alleviate your symptoms. Remember, this trial is specifically looking for participants who have not found relief through other means, so it may offer new hope for managing your pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * The patients claim orofacial pain. The pain has been treated but not relieved by medication, surgery, root canal therapy, even teeth extracting, or the pain relieve effect went down for a period. The patients also match the following item 1 or 2:
- • Item 1: disorder characterized by recurrent unilateral brief electric shock-like pains, abrupt in onset and termination, limited to the distribution of one or more divisions of the trigeminal nerve and triggered by innocuous stimuli. It may develop without apparent cause or be a result of another diagnosed disorder. There may or may not be, additionally, persistent background facial pain of moderate intensity.They fulfilled criteria A-E
- • At least three attacks of unilateral facial pain fulfilling criteria B and C
- • Occurring in one or more divisions of the trigeminal nerve, with no radiation beyond the trigeminal distribution
- * Pain has at least three of the following four characteristics:
- • recurring in paroxysmal attacks lasting from a fraction of a second to 2 minutes.
- • severe intensity.
- • electric shock-like, shooting, stabbing or sharp in quality.
- • precipitated by innocuous stimuli to the affected side of the face.
- • No clinically evident neurological deficit
- • Not better accounted for by another the International Classification of Headache Disorders 3rd edition diagnosis.
- • Item 2 Persistent facial and/or oral pain, with varying presentations but recurring daily for more than 2 hours per day over more than 3 months, in the absence of clinical neurological deficit.They fulfilled criteria A-E
- • Facial and/or oral pain fulfilling criteria B and C
- • Recurring daily for \>2 hours per day for \>3 months
- • Pain has both of the following characteristics: 1. poorly localized, and not following the distribution of a peripheral nerve 2. Dull, aching or nagging quality
- • Clinical neurological examination is normal
- • A dental cause has been excluded by appropriate investigations
- • Not better accounted for by another the International Classification of Headache Disorders 3rd edition diagnosis
- Exclusion Criteria:
- • Head and facial trauma; orofacial and/or intracranial space occupying lesion indicated by craniofacial CT ; pain caused by sinusitis and acute pulpitis, periapical periodontitis and periodontitis disease; no occlusal abnormalities and occlusion treatment indications through a series of occlusal examination; children (younger than 18 years old) and pregnant women.
About Meiqing Wang
Meiqing Wang is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a strong emphasis on collaboration and transparency, Meiqing Wang leads a team of experienced professionals committed to designing and conducting high-quality clinical studies. The organization prioritizes rigorous adherence to regulatory standards and ethical practices, ensuring the safety and well-being of participants. By leveraging cutting-edge methodologies and fostering partnerships with healthcare institutions, Meiqing Wang aims to contribute significantly to the development of new treatments and enhance the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, Shaanxi, China
Patients applied
Trial Officials
Shaoxiong Guo, M.D
Study Chair
State Key Laboratory of Military Stomatology, Department of Oral Anatomy and Physiology and TMD,School of Stomatology, The Fourth Military Medical University, Xi 'an, China.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials